In a post-hoc analysis of AWARD-11, the effect of dulaglutide treatment was associated with consistent safety and efficacy patterns regardless of their renal function status at baseline, with no more gastrointestinal adverse effects nor hypoglycemic events in those subjects with lower renal function [95]
The application itself is virtually painless due to the numbing qualities of the Phenol component
Publishers Note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Some patients on GLP-1 therapy see regain when stopped if dietary habits weren't changed this is a habits issue, not a compound dependency
Preventing desensitization Cycling is the primary prevention strategy
Structureactivity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness